45 algorithm-development-"Multiple"-"Simons-Foundation"-"Prof"-"UNIS" positions at University of Basel
Sort by
Refine Your Search
-
discovery and development through in vitro modelling of in-patient conditions in order to address antibiotic resistance, a problem of global importance. To reach this goal, AntiResist has assembled a panel of
-
probe microscopy. Our research focuses on using single electron spins in diamond as sensors to explore magnetic phenomena at the nanoscale. This doctoral project will center around the development and
-
disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 800 employees, the Department of Biomedicine is the largest
-
develop new therapies for vision loss. It is a place where your expertise will be valued, your abilities challenged, and your knowledge expanded. Position Overview We are seeking a motivated Research
-
at the interface of bacterial signal transduction and phage biology. Our research group at the Biozentrum is embedded in the National Centre of Competence in Research (NCCR) AntiResist. We develop and use state
-
of adaptive radiation and associated key innovations in the evolution of freshwater diatoms. By integrating morphology, physiology, genomics, transcriptomics, and computational modeling, we aim to (i) determine
-
, networking, and career development are located in Basel. Basel provides a high standard of living and a rich and varied cultural atmosphere.
-
to solve fundamental questions surrounding evolution and interaction between bacteria and bacteriophages. The Biozentrum provides a highly stimulating collaborative research environment with a
-
basic and clinical scientists to advance our understanding of health and disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research
-
well as to develop radically new therapies for eye diseases. These therapies are urgently needed, since the prevalence of visual diseases is rising globally, and effective therapies are lacking for most of them. As